Free Trial

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Sees Large Increase in Short Interest

Aspen Pharmacare logo with Medical background

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY - Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,000 shares, an increase of 566.7% from the March 31st total of 300 shares. Approximately 0.0% of the company's shares are sold short. Based on an average daily volume of 2,000 shares, the short-interest ratio is currently 1.0 days.

Aspen Pharmacare Price Performance

OTCMKTS:APNHY traded down $0.29 during trading hours on Thursday, hitting $6.30. The stock had a trading volume of 234 shares, compared to its average volume of 1,359. Aspen Pharmacare has a 1-year low of $5.76 and a 1-year high of $13.69. The company has a quick ratio of 1.07, a current ratio of 1.81 and a debt-to-equity ratio of 0.30. The business has a 50 day simple moving average of $8.68 and a two-hundred day simple moving average of $9.19.

About Aspen Pharmacare

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

See Also

Should You Invest $1,000 in Aspen Pharmacare Right Now?

Before you consider Aspen Pharmacare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.

While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines